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Background:  Although  amyotrophic  lateral  sclerosis  (ALS)  is  a  relentlessly  progressive  disorder,  early
diagnosis  allows  a prompt  start  with  the  speciﬁc  drug  riluzole  and  an accurate  palliative  care  planning.  ALS
at onset  may  however  mimic  several  disorders,  some  of them  treatable  (e.g.,  multifocal  motor  neuropathy)
or  epidemiologically  more  frequent  (e.g.,  cervical  myelopathy).
Objective:  To  study  the  delay  from  onset  to  diagnosis  in  a cohort  of  ALS  patients  and  to the  variables  that
may affect  it.
Methods:  We  performed  a  retrospective  analysis  of the  diagnostic  delays  in  a cohort  of 260  patients
affected  by  ALS  (M/F  =  1.32)  followed  at  our  tertiary  referral  ALS  Center  between  2000  and  2007.
Results:  The  median  time  from  onset  to  diagnosis  was  11  months  (range:  6–21)  for the  whole  ALS  cohort,
10  months  (range:  6–15)  in  bulbar-onset  (n  = 65)  and  12  months  (range:  7–23)  in  spinal-onset  (n  =  195)
patients  (p  = 0.3).  31.1%  of  patients  received  other  diagnoses  before  ALS  and  this  led  to a  signiﬁcant
delay  of  the  correct  diagnosis  in this  group  (other  diagnoses  before  ALS,  n  = 81: median  delay,  15  months
[9.75–24.25]  vs ALS,  n =  179,  median  delay,  9 months  [6–15.25],  p <  0.001).
Conclusions:  The  diagnostic  delay  in  ALS  is  about  one  year,  besides  the  growing  number  of  tertiary  centres
and  the  spread  of  information  about  the  disease  through  media  and  internet.  Cognitive  errors  based  on
an incorrect  use  of  heuristics  might  represent  an important  contributing  factor.  Furthermore,  the length
of the  differential  diagnosis  from  other  disorders  and  delays  in  referral  to the  neurologist  seems  to be
positively  associated  with  the  delay  in diagnosis.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Amyotrophic lateral sclerosis (ALS) is a degenerative disease of
the adult life, characterized by a progressive loss of spinal, bul-
bar and cortical motor neurons and, consequently, muscle wasting,
dysphagia, dysarthria, and respiratory impairment. Death usually
occur within 3–5 years after onset, the main cause being the
respiratory failure [1].  Although the established pharmacological
therapy for ALS, i.e.  riluzole, allows an increase in survival [2],
patients greatly beneﬁt from the highly specialized palliative care,
which is now best provided by tertiary referral Centres [3–5].
The diagnosis of ALS is mainly based on a clinical approach and
supported by negative neuroimaging. Full nerve conduction studies
and conventional EMG  are very important in the diagnostic workup
[6,7]. A recent consensus conference held by the Awaji Group estab-
lished the equivalence of electrophysiological signs of lower motor
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neuron dysfunction to the clinical signs, making redundant the
early category of “Laboratory-supported probable ALS” [7].  In addi-
tion, in the same conference it was  established the equivalence,
as a sign of acute denervation, between the fasciculation poten-
tials and the ﬁbrillation potentials and acute sharp waves [7].  Taken
together, these two  suggestions should increase the sensitivity of
the diagnostic criteria and allow earlier diagnosis [7].
As ALS shows almost invariably a subtle onset, early diagnosis
can be difﬁcult in ALS, despite the growing number of clinical tri-
als which undoubtedly encourage researchers to put much effort
on a timely identiﬁcation of the disorder. Previous studies have
shown, in fact, little change in the diagnostic delay in ALS, with
a median delay from onset to diagnosis of about 9–13 months
[5,8–11].
The concept of “earlier is better” in the diagnosis of ALS bears
signiﬁcant implications in order to access to an appropriate man-
agement and care. Besides the available pharmacologic therapy, a
high-quality and appropriate palliative care has been demonstrated
to have a positive impact on the disease course, and hence on the
patients’ quality of life and survival [12–16].
The objective of the present study was to describe those factors
that may  delay the diagnosis in ALS and to discuss the potential for
improvement.
0303-8467/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
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2. Patients and methods
Two-hundred and sixty clinically probable or deﬁnite ALS
patients (M/F = 1.32) were diagnosed according to El-Escorial/WFN
criteria [6] and followed by our Tertiary Referral Centre during a
seven-years period (2000–2007).
We made a complete diagnostic work-up in 97 patients (37.3%),
while the remaining 163 patients (62.7%) were referred to us from
other Centres/Hospitals. All patients underwent a complete clin-
ical evaluation, EMG and nerve conduction studies, brain and/or
cervical MRI  (the imaging studies were performed in over 85% of
patients), and an extensive biochemical workup. This included a
lumbar puncture in over 80% of patients.
One-hundred and ninety-ﬁve patients were spinal-onset (75%),
whereas in sixty-ﬁve patients the onset was bulbar (25%). Two-
hundred and ﬁfty patients (96.1%) were regularly taking riluzole
(100 mg/day). The median age (years) and interquartile range (IQR)
of the ALS patients at onset was 60 (51–67).
Each patient, either during the diagnostic work-up at our ALS
Centre or when referred by other Hospitals/Centres, underwent a
detailed interview on when and how the symptoms began, and
the type of diagnostic work-up and specialists who made the
ﬁrst visits. Dysarthria was the most frequent ﬁrst symptom com-
plained by bulbar-onset ALS patients, followed by dysphagia and
pseudobulbar manifestation. Muscular atrophy, weakness and, less
frequently, fasciculations in one or more limbs were the common
initial complaint of spinal-onset patients. Gait disturbance were
less frequently reported at onset by this group of patients. In a
few cases disease apparently started with a progressive respira-
tory failure or with cognitive changes. Furthermore, it was  noted
whether other diagnoses were made before ALS. The interview was
not formally structured, however we took care to go through all the
following points: (i) when the patients noticed the ﬁrst symptoms
(the month), and what symptom caught his/her attention and led
to seeking medical help; (ii) when was the ﬁrst specialist referral
made and what was the ﬁrst diagnosis; (iii) when was  the ﬁrst neu-
rologist referral made; iv) when the correct diagnosis was made.
All data concerning the 260 patients followed were stored in
a database (Access, Microsoft®) and the corresponding medical
records reviewed. We  could therefore establish: (a) the delay from
onset to the correct diagnosis; (b) how many specialists were
sought with particular reference to the ﬁrst neurologist; (c) what
diagnosis was made before the diagnosis of ALS, and (d) how much
an initially wrong diagnosis delayed the correct one.
We compared different groups of patients: men  and women,
patients at different ages, patients with bulbar and spinal symp-
toms at the beginning of the disease.
All analyses were done using SIGMASTAT 3.5 software package
(Systat Software Inc., San José, CA, USA). The main demographic
and clinical characteristics of the ALS patients were analysed using
medians with interquartile ranges (IQ) and differences between
groups assessed with Mann–Whitney’s ranks sum test. All corre-
lations were studied using Spearman’s rank correlation coefﬁcient.
A Multivariate logistic regression analysis was performed to assess
which variables are likely to be associated with initial misdiagnosis.
Dichotomous independent variables were gender, site of onset and
neurologist as ﬁrst physician seen; continuous independent vari-
ables were age at onset and the diagnostic delay. p values < 0.05
were considered signiﬁcant.
Our Institutional Ethic Committee reviewed and approved this
study.
3. Results
Table 1 shows the demographic and clinical characteristics of
the 260 ALS patients included in this study. 148 (57%) were men  and
Table 1
Demographic and clinical characteristics of the ALS patients.
ALS p
Age at onset (years), median [IQ range]
All (n = 260) 60.0 [51–67]
Bulbar-onset (n = 65, 25%) 63.0 [54–70]
Spinal-onset (n = 195, 75%) 59.0 [50–66] 0.018a
M/F
All (n = 260) 1.32
Bulbar-onset (n = 65) 0.80
Spinal-onset (n = 195) 1.56
a Mann–Whitney’s rank sum test.
112 (43%) were women, with a M/F  ratio of 1.32. Patients were strat-
iﬁed by site of disease onset: 65 were bulbar (25%, M/F  = 0.8) and
195 were spinal (75%, M/F  = 1.56). Dysphagia and dysarthria were
almost invariably the symptoms at onset in the bulbar patients.
Among the spinal-onset group, ﬁrst symptoms (e.g., weakness, fas-
ciculations) were almost equally distributed between upper limbs
(UL) and lower limbs (LL): onset UL, n = 91 (46.5%) vs onset LL,
n = 103 (53%). In one patient onset was with respiratory deﬁcit
(0.5%).
The median age at onset (years) was 60 [IQ range: 51–67] for
the entire cohort; the bulbar-onset group was however older than
the spinal-onset group (bulbar, 63 [IQ range: 54–70] vs spinal, 59
[IQ range: 50–66], p = 0.018, Mann–Whitney’s rank sum test).
3.1. The diagnostic delay in ALS
As outlined above (see Section 2), onset of the disease was estab-
lished from the patient’s history (i.e., month when ﬁrst symptom
appeared). The month of diagnosis was instead that in which a ﬁrst
written report with “ALS or motor neuron disease” was  given to the
patient. At the time of diagnosis, a clinical categorization accord-
ing to El-Escorial was  performed (6). In all patients of our cohort,
a complete EMG/nerve conduction study was  available before the
ﬁrst diagnosis of ALS/motor neuron disease was  formally raised.
This underscore the importance of the neurophysiological studies
on the diagnostic process of ALS.
The median time from clinical onset to diagnosis in the whole
cohort was  11 months [IQ range: 6–21]. In the bulbar-onset patients
the delay appeared slightly shorter (median: 10 months [IQ range:
6–15]), whereas we  found the opposite in the spinal-onset group
(median: 12 months [IQ range: 7–23]. The difference was how-
ever not signiﬁcant (p = 0.25, Mann–Whitney’s rank sum test), even
when groups were stratiﬁed by sex (data not shown). Median time
to diagnosis was  10 months [IQ range: 6–21] for men and 11 months
[IQ range: 6–19] for women  (p = 0.707).
As shown in Fig. 1, after symptoms onset, it took a median time
of three months [IQ range: 1–7] to see a doctor, and six months
[IQ range: 3–12] to be observed by a second physician. The latter
in the vast majority of cases (over 90%) was a neurologist. Note
that bulbar-onset patients sought for a physician earlier than those
spinal-onset (bulbar, 2 months [IQ range: 1–5.5] vs Spinal, 3 months
[IQ range: 1–8.25], p = 0.02, Mann–Whitney’s rank sum test). The
elapsed time from ﬁrst to second visit was instead no signiﬁcantly
different between bulbar-onset and spinal-onset patients (bulbar,
median 6 months [IQ range: 4–11] vs Spinal, median 7 months
[IQ range: 3–12], p = 0.83). Therefore, while bulbar-onset patients
are looking for a physician slightly earlier than those spinal-onset,
a neurologist (who almost invariably was  the second physician
sought) is seen only after several months, irrespective of the site
of onset.
We then investigated which physician was likely to be ﬁrst seen
according to the site of onset and asked whether this may  have
some impact on the diagnostic delay. Most bulbar ALS consulted
Author's personal copy
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Fig. 1. Median elapsed time (months) between ﬁrst symptoms leading to ALS and
physician consultation. The horizontal bars indicate the whole ALS cohort (all,
n  = 260), the bulbar-onset (bulbar, n = 65) and the spinal-onset (spinal, n = 195)
subgroups. Black bars indicate the elapsed time between onset (T0) and the appear-
ance of ﬁrst symptoms. Bulbar-onset patients consulted a physician earlier than
the spinal-onset patients (p = 0.02, time from onset to ﬁrst physician consulted by
bulbar-onset patients vs spinal onset, Mann–Whitney’s rank sum test). Grey bars
indicate the timing between ﬁrst physician consultation and second physician con-
sultation (p < 0.001, ﬁrst physician vs second physician, Mann–Whitney’s rank sum
test). Note that in the vast majority of cases (over 90%) the second physician was  a
neurologist. Dark grey bars show the timing between the second physician consul-
tation and the ﬁnal diagnosis.
an otolaryngologist (35%), followed by a general practitioner (GP,
31%) and a neurologist (26%); almost half of the spinal ALS ﬁrst
sought for a neurologist (49%), followed by a GP (24%) and an
orthopaedics (16%). In summary, a neurologist was the ﬁrst physi-
cian to be sought by 113 patients with a median delay of ﬁve months
after onset [IQ range: 2–12], whereas the remaining 147 were ﬁrst
visited by another physician/specialist only 2 months after onset [IQ
range: 1–5], p < 0.001 rank sum test. The difference was  however
completely lost when the ﬁnal diagnosis was reached (median diag-
nostic delay in patients ﬁrst seen by: (i) a neurologist, 11 months
[IQ range: 6–18] vs (ii) another physician/specialist, 11 months [IQ
range: 6–24], p = 0.97). This suggests that the diagnostic pathway
to ALS is a complex process that is not shortened when a patient is
ﬁrst seen by a neurologist.
Almost one-third of the patients in our cohort received other
diagnoses (31.1%, n = 81) before the correct one, and in 36 (44.4%)
the initial misdiagnosis was made by a neurologist. Receiving an
incorrect diagnosis led to a signiﬁcant delay in reaching the right
one in this group (other diagnoses before ALS, n = 81: median
delay, 15 months [IQ range: 9.75–24.25] vs ﬁrst diagnosis as ALS,
n = 179, median delay, 9 months [IQ range: 6–15.25], p < 0.001,
Mann–Whitney’s rank sum test). A similar outcome was seen
when the patients were grouped according to the site of onset
(bulbar-onset: other diagnoses before ALS, n = 24: median delay,
12 months [IQ range: 8–16.5] vs ﬁrst diagnosis as ALS, n = 41,
median delay, 7 months [IQ range: 5–15], p = 0.08, Mann–Whitney’s
rank sum test; Spinal-onset: other diagnoses before ALS, n = 57:
median delay, 17 months [IQ range: 11.75–29.5] vs ﬁrst diagnosis as
ALS, n = 41, median delay, 10 months [IQ range: 6–16.5], p < 0.001,
Mann–Whitney’s rank sum test). The type of symptoms at onset
and the speciﬁc regional location did not signiﬁcantly affect the
initial misdiagnosis (data not shown).
The most common misdiagnoses are listed in Table 2. The
majority of initial wrong diagnoses were discal hernia and cervical
myelopathy (32%) or vascular pseudobulbar palsy (20%), with little
difference between neurologists and non-neurologist physicians.
We then assessed which variable is likely to be associated with
the risk of misdiagnosis. As shown in Table 3, a multivariate logistic
analysis suggested that the spinal onset of the disease correlates
Table 2
Most common misdiagnoses at onset in ALS.
Diagnoses Overall By a physician By a neurologist
(n  = 81) n (%) n (%)a n (%)a
Arthrosis 2 (2.4) 1 (50) 1(50)
Alzheimer dementiab 4 (5.0) 3 (75) 1 (25)
Depression 5 (6.2) 3 (60) 2 (40)
Discal hernia/cervical
myelopathy
26 (32.0) 12 (46) 14 (54)
Vascular pseudobulbar
palsy
16 (20.0) 12 (75) 4 (25)
Myasthenia 6 (7.4) 3 (50) 3 (50)
Neuropathy/myopathy 7 (8.6) 4 (57) 3 (43)
Parkinson disease 4 (5.0) 2 (50) 2 (50)
Thyroid dysfunction 2 (2.4) 2 (100) 0 (0)
Carpal tunnel syndrome 5 (6.2) 3 (60) 2 (40)
Multiple sclerosis 2 (2.4) 0 (0) 2 (100)
Stroke 1 (1.2) 0 (0) 1 (100)
Essential tremor 1 (1.2) 0 (0) 1 (100)
a Percent value in relationship to the number of diagnoses in the speciﬁc category.
b Two of the patients initially diagnosed by neurologists as having Alzheimer
dementia.
positively with a higher risk of misdiagnosis. Being ﬁrst visited by
a neurologist conferred instead a slight lower risk of misdiagnosis.
In both cases, however, the associations were not signiﬁcant.
4. Discussion
This retrospective study involved a cohort of 260 ALS patients
followed in a single tertiary referral centre, and it showed that
the diagnostic delay is less than one year being slightly shorter
in bulbar-onset patients. This appears to be similar to the ﬁnd-
ings of previous studies [5,8–11,13,17–20], and it is in part related
to misdiagnoses, the most frequent being discal hernia/cervical
myelopathy and vascular pseudobulbar palsy. Furthermore, an
early consultation with a neurologist does not seem to shorten the
diagnostic delay.
Several years after the establishment of the clinical criteria for
the diagnosis of ALS [6] and the growing public awareness about the
disease, the diagnostic delay does not appear to have been short-
ened despite the fact that most patients have free access to the
Internet and/or they refer to a physician relatively early after symp-
toms onset and a neurologist is growingly often sought. This might
in part be related to the putative negative impact of physician-
related cognitive and psychological variables [8].
Several studies have focused on the diagnostic delay in ALS.
The delay have been reported to range between eight and more
than ﬁfteen months (Table 4), with little improvement over the
last years [8,11,13,18–21],  even after the creation of tertiary mul-
tidisciplinary ALS centres and prospective surveillance registries
[4,5,9,10,17,22]. The delay is never less than eight months, although
patients usually refer to a physician some three months after symp-
toms onset. The median delay from disease onset to diagnosis was
calculated from the studies shown in Table 4, most of them carried
out in the last two decades, and showed to be 11.7 months. We
found a strikingly similar delay, even though a potential drawback
of the present study is that it is based on a cohort from a tertiary
referral centre. The availability of detailed clinical criteria [6] and
Table 3
Multivariate analysis of misdiagnosis risk in the ALS cohort.
Independent variable Odds ratio 95% CI p
Male gender 0.97 0.56–1.68 0.91
Age  at onset 1.00 0.92–1.03 0.62
Diagnostic delay 1.02 1.00–1.03 0.017
Spinal onset 1.54 0.82–2.88 0.17
Neurologist as ﬁrst physician seen 0.86 0.49–1.50 0.61
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Table 4
Summary of different studies on the diagnostic delay from onset to diagnosis in
amyotrophic lateral sclerosis.
Study Period Delay (months) Ref.
Czaplinski et al. (2006) 1984–1999 12.99 [13]
1999–2004 14.21 [13]
Traynor et al. (2000) 1993–1998 8.0 [17]
Chiò et al. (2002) 1995–1996 11.1 [21]
Chiò et al. (2009) 1995–2004 10.4 [10]
Belsh and Schiffmann (1996) N.I.a 12.3 [19]
Kraemer et al. (2010) N.I.a 10.5 [11]
Househam and Swash (2000) 1995–1999 13.0 [8]
Zoccolella et al. (2006) 1998–1999 9.3 [9]
Donaghy et al. (2008) 2006b 15.6 [29]
Present study 2000–2007 11.0 [–]
a N.I., not indicated: the exact period is not shown in the study.
b Prevalent cases on 1st January 2006 from Northern Ireland Register. The median
diagnostic delay calculated from all studies (the present study is not included) is 11.7
months [IQ range: 10.4–13.0].
the opportunity to perform an accurate laboratory, EMG  studies
and imaging workup do not seem to be of much help in shortening
the diagnostic delay and cut off misdiagnoses. In particular, the fre-
quency of initial misdiagnoses was 27% [18], 44% [11], 45% [22] and
61% [8] in several studies. We  found a 31.1% of initial misdiagnoses
which brought about a longer delay to the right diagnosis (i.e., 15
months), a result similar to that reported by Househam and Swash
[8]. 44.4% of initial misdiagnoses were made by a neurologist in our
study. This result is slightly higher than that reported in a survey,
where 28% of misdiagnoses were made by neurologists [22].
The diagnostic delay appeared to be only slightly shorter when
the patient had a bulbar-onset (10 months), and we  found no sig-
niﬁcant differences with respect to the spinal-onset group. The lack
of a signiﬁcant difference in the diagnostic delay between bulbar-
and spinal-onset patients was similarly reported by Chiò et al.
[20], whereas in other studies the opposite was found [11,23]. The
diagnostic delay in bulbar-onset patients however ranges between
8 and 10 months in the majority of reports. In conclusion, even
though the patients in this subgroup generally refer earlier to a
physician this does not allow them to receive a prompt diagnosis.
A question arises of why, besides the establishment of mainly
clinically-based criteria for the diagnosis of ALS [6] and the spread of
information about the disease, the diagnostic delay is still about one
year, that is nearly one-third of the natural history of the disease [1].
Furthermore, being ﬁrst observed by a neurologist does not seem
to shorten the diagnostic delay.
ALS is a terrible disease, with no speciﬁc therapy able to arrest its
progressive course. Raising a suspect of ALS and then breaking the
news to the patient and relatives is a difﬁcult task. Several papers
have been devoted to this important step [3,24,25] and there is
general awareness that this is a key step in the diagnostic and man-
agement process. Recently, several works have been dedicated to
cognitive errors that physicians make in their diagnostic work-up
[26,27]. These may  lead to missed diagnoses or mismanagement
by neurologists [27]. Given that the logistic regression analysis
showed initial misdiagnosis in ALS is unrelated to variables as sex,
age at onset, diagnostic delay, site of onset, and being ﬁrst observed
by a neurologist, we suggest that cognitive errors, with particu-
lar reference to framing effects and anchoring heuristics [27], may
at least in part play a relevant role in the diagnostic delay in ALS.
The fact that most misdiagnoses of ALS (over 50% in our study)
are disk hernia/myelopathy and cerebrovascular disease supports
this hypothesis. Symptoms and signs of ALS can in fact easily be
framed in and anchored to these two common pathological condi-
tions. Moreover, there are reports showing how much ALS patients
undergo unnecessary surgery, peaking to more that 20% of cases
[11,28].
Even after careful correction for cognitive errors and a rigid
application of the criteria for the diagnosis of ALS [6,27],  we  believe
that a delay from onset to diagnosis in ALS cannot be reduced below
three/four months for spinal-onset patients and one-two months
for bulbar-onset patients.
An important variable that may  greatly improve the diagno-
sis of ALS is the careful evaluation of the clinical progression of
the symptoms. It is unlikely that hernia and vascular pseudobul-
bar palsy, which both account for by over 50% of all misdiagnoses,
show a progression comparable to most ALS patients. In addition, a
careful and extensive EMG  and nerve conduction study is essential
in shortening the diagnostic delay. In particular, the recent Awaji
criteria [7] enable early detection of electrophysiological abnor-
malities in apparently unaffected limbs and outside the region of
clinical onset [29]. Slowly progressing patients have to be followed
up carefully and when only lower motoneuron signs and symptoms
are apparent, common ALS-mimic disorders (e.g., Kennedy disease
and [multifocal] motor neuropathy) have to be ruled out [30].
In conclusion, our study shows that the diagnostic delay in ALS
is almost one year. Even with improved diagnostic tools, the estab-
lishment of careful clinical criteria and higher public awareness it
appears to have undergone little variation over the years. Cogni-
tive variables affecting the medical decision may  play a role, and
this seem to involve also neurologists, which partially contribute
to a delayed diagnosis and misdiagnoses. A better clinical approach
to the diagnosis, rather than mostly relying on laboratory tests
and imaging techniques, may  allow a signiﬁcant reduction of the
diagnostic delay in this devastating disorder.
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